COVID-19 Evidence Accelerator:
What We've Learned, Where We're Headed

Thursday, October 20, 2022

In the midst of a global pandemic, the Reagan-Udall Foundation for the FDA, along with Friends of Cancer Research, created an unprecedented regulatory science collaborative to share real-world data and to generate innovative responses on how to deal with COVID-19. 

On October 20, 2022, we highlighted the accomplishments and shared learnings from more than 200 meetings, and 275 expert presentations, including how best to leverage real-world data and improve data interoperability to address current and future health challenges.

Since its inception at the request of the FDA, the COVID-19 Evidence Accelerator has been a forum for key players across the health care ecosystem to share real-world data and evaluate new diagnostics, treatments, and vaccines for COVID-19. The Evidence Accelerator provided a unique framework for sharing and advancing ideas.